Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
Cancer Research UK · Queen Mary University of London · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,687
total citations
- FWCI
- 98.22
- Percentile
- 100%
- References
- 27
Citations per year
Authors
7- JCJack CuzickCorresponding
Cancer Research UK, Queen Mary University of London
- IŠIvana Šestak
Queen Mary University of London, Cancer Research UK
- MBMichael Baum
Cancer Research UK, University College London
- AUAman U. Buzdar
The University of Texas MD Anderson Cancer Center
- AHAnthony Howell
Cancer Research UK, University of Manchester
Topics & keywords
Topics
Keywords
- Anastrozole
- Tamoxifen
- Medicine
- Breast cancer
- Hazard ratio
- Internal medicine
- Population
- Oncology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.